Alcon buying Irvine eye tech firm Ivantis for $475 million
Alcon buying Irvine eye tech firm Ivantis for $475 million
A Swiss medical company is acquiring Irvine-based Ivantis Inc. for $475 million, the company announced Monday.
Ivantis, with its headquarters on Technology Drive, makes a tiny implant that helps patients suffering from glaucoma, a disease that creates a buildup of ocular fluid and pressure in the eye. Too much pressure and the affected patient can suffer from blurry vision, headaches and even…
Discover more from USNewsRank
Subscribe to get the latest posts sent to your email.